We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNC
2451
DELISTED
Spectranetics Corp
SPNC
| $325K | ﹤0.01% |
27,608
-534
| -2% | -$9.56K |
|
|
COWN
2452
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $325K | ﹤0.01% |
17,816
-1,133
| -6% | -$24.9K |
|
|
RGC
2453
DELISTED
Regal Entertainment Group
RGC
| $323K | ﹤0.01% |
17,289
+4,868
| +39% | +$93.9K |
|
|
PINC
2454
DELISTED
Premier
PINC
| $322K | ﹤0.01% |
9,357
-146,901
| -94% | -$5.29M |
|
2455
Enterprise Financial Services Corp
EFSC
$2.42B
| $321K | ﹤0.01% |
12,739
-865
| -6% | -$20.7K |
|
2456
Iridium Communications
IRDM
$4.81B
| $321K | ﹤0.01% |
52,188
-2,077
| -4% | -$15.1K |
|
2457
SunCoke Energy
SXC
$779M
| $320K | ﹤0.01% |
41,180
-2,143
| -5% | -$23.9K |
|
2458
OneSpan
OSPN
$572M
| $318K | ﹤0.01% |
18,671
-39,359
| -68% | -$809K |
|
2459
Teekay Tankers
TNK
$2.66B
| $318K | ﹤0.01% |
5,767
+428
| +8% | +$23.1K |
|
2460
vTv Therapeutics
VTVT
$122M
| $318K | ﹤0.01% |
+1,219
| New | +$425K |
|
2461
CBIZ
CBZ
$2.51B
| $317K | ﹤0.01% |
32,319
+904
| +3% | +$8.81K |
|
2462
NN Inc
NNBR
$261M
| $317K | ﹤0.01% |
17,128
+4,705
| +38% | +$109K |
|
2463
Helix Energy Solutions
HLX
$1.35B
| $316K | ﹤0.01% |
65,997
-2,499
| -4% | -$19.9K |
|
2464
Artisan Partners
APAM
$2.9B
| $315K | ﹤0.01% |
8,945
+3,593
| +67% | +$155K |
|
|
MRGE
2465
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $315K | ﹤0.01% |
44,400
-4,885
| -10% | -$30.8K |
|
|
CSII
2466
DELISTED
Cardiovascular Systems, Inc.
CSII
| $312K | ﹤0.01% |
19,684
-625
| -3% | -$15.8K |
|
|
HNGR
2467
DELISTED
Hanger Inc.
HNGR
| $312K | ﹤0.01% |
22,858
-436
| -2% | -$8.39K |
|
|
HTO
2468
H2O America
HTO
$2.69B
| $311K | ﹤0.01% |
10,113
+102
| +1% | +$3.03K |
|
|
LDL
2469
DELISTED
Lydall, Inc.
LDL
| $311K | ﹤0.01% |
10,923
-690
| -6% | -$19.7K |
|
2470
1st Source
SRCE
$2.18B
| $309K | ﹤0.01% |
10,038
-127
| -1% | -$3.88K |
|
2471
Supernus Pharmaceuticals
SUPN
$2.77B
| $309K | ﹤0.01% |
21,994
+330
| +2% | +$6.14K |
|
2472
Paylocity
PCTY
$7.43B
| $306K | ﹤0.01% |
10,211
+120
| +1% | +$4.08K |
|
|
UBA
2473
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $306K | ﹤0.01% |
16,306
| – | – |
|
|
COBZ
2474
DELISTED
CoBiz Financial,Inc
COBZ
| $306K | ﹤0.01% |
23,512
-947
| -4% | -$12.2K |
|
|
TBRG
2475
DELISTED
TruBridge
TBRG
| $304K | ﹤0.01% |
7,208
-224
| -3% | -$10.8K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.